We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$6.71B
AUM Growth
+$2.5B
Cap. Flow
+$2.05B
Cap. Flow %
30.61%
Top 10 Hldgs %
14.85%
Holding
2,565
New
44
Increased
937
Reduced
347
Closed
1,235

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$92.8M
2
MSFT icon
Microsoft
MSFT
+$58.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$56.5M
4
XOM icon
ExxonMobil
XOM
+$46.3M
5
CVX icon
Chevron
CVX
+$29.4M

Sector Composition

Rank Sector Weight
1 Financials 18.32%
2 Technology 15.24%
3 Healthcare 12.35%
4 Industrials 9.18%
5 Consumer Discretionary 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
1101
Sarepta Therapeutics
SRPT
$1.66B
$393K 0.01%
19,292
-13,663
-41% -$406K
SGNT
1102
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$389K 0.01%
15,335
+4,794
+45% +$108K
BRKL
1103
DELISTED
Brookline Bancorp
BRKL
$386K 0.01%
40,385
-28,929
-42% -$263K
GTLS
1104
DELISTED
Chart Industries
GTLS
$386K 0.01%
4,038
-16,384
-80% -$1.72M
PPO
1105
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$384K 0.01%
9,860
-22,437
-69% -$884K
CADX
1106
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$383K 0.01%
42,358
-26,836
-39% -$194K
FCF icon
1107
First Commonwealth Financial
FCF
$2.12B
$382K 0.01%
43,329
-45,305
-51% -$390K
VPHM
1108
DELISTED
VIROPHARMA INC
VPHM
$381K 0.01%
7,649
-59,753
-89% -$2.67M
KYTH
1109
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$380K 0.01%
10,203
+3,763
+58% +$156K
INSY
1110
DELISTED
Insys Therapeutics, Inc.
INSY
$379K 0.01%
+29,385
New +$408K
CNC icon
1111
Centene
CNC
$31.3B
$376K 0.01%
25,520
-122,440
-83% -$1.83M
MDSO
1112
DELISTED
Medidata Solutions, Inc.
MDSO
$376K 0.01%
6,208
-29,322
-83% -$1.62M
PRK icon
1113
Park National Corp
PRK
$3.41B
$371K 0.01%
4,359
-5,401
-55% -$439K
OMED
1114
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$371K 0.01%
+12,578
New +$230K
TYL icon
1115
Tyler Technologies
TYL
$12.2B
$369K 0.01%
3,614
-17,369
-83% -$1.69M
SEMG
1116
DELISTED
SEMGROUP CORPORATION
SEMG
$367K 0.01%
5,628
-22,725
-80% -$1.37M
MIDD icon
1117
Middleby
MIDD
$6.05B
$360K 0.01%
4,497
-31,254
-87% -$2.31M
KATE
1118
DELISTED
Kate Spade & Company
KATE
$355K 0.01%
11,080
-68,038
-86% -$2.01M
FEIC
1119
DELISTED
FEI COMPANY
FEIC
$350K 0.01%
3,920
-23,670
-86% -$2.1M
INFI
1120
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$341K 0.01%
24,672
-22,424
-48% -$317K
WLK icon
1121
Westlake Corp
WLK
$9.46B
$340K 0.01%
+5,570
New +$313K
AGIO icon
1122
Agios Pharmaceuticals
AGIO
$2.16B
$339K 0.01%
+14,172
New +$323K
STBA icon
1123
S&T Bancorp
STBA
$1.86B
$339K 0.01%
13,397
-13,550
-50% -$334K
ON icon
1124
ON Semiconductor
ON
$33.8B
$338K 0.01%
41,052
+8,028
+24% +$58.6K
ARRS
1125
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$337K 0.01%
13,835
-64,235
-82% -$1.23M

Similar funds

ProShare Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, ProShare Advisors held 2,565 positions worth $6.71B, up 59% from $4.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

ProShare Advisors deployed $2.05B of net new capital in Q4 2013, opening 44 new positions and adding to 937 existing holdings. Its largest new stake was VEON: 13,524 shares worth $4.38M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was CoStar Group, an estimated $2.8M trimmed.

  • ProShare Advisors's largest Q4 2013 buy was VEON: 13,524 shares worth $4.38M.
  • ProShare Advisors added most to Apple in Q4 2013, an estimated $92.8M increase.
  • ProShare Advisors's biggest Q4 2013 reduction was CoStar Group, cutting an estimated $2.8M.
  • ProShare Advisors fully exited DELL INC in Q4 2013, selling an estimated $4.89M.
  • ProShare Advisors's ten largest holdings make up 15% of its $6.71B portfolio in Q4 2013.
  • ProShare Advisors opened 44 new positions and closed 1,235 in Q4 2013.
  • ProShare Advisors's portfolio value rose 59% quarter-over-quarter to $6.71B.

Based on ProShare Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.